Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for bone marrow fibrosis in primary myelofibrosis
RBR-52ty66Phase 2Recruiting
- Sponsor
- São Paulo Research Foundation
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metformin in primary myelofibrosis (PMF), sponsored by São Paulo Research Foundation. Primary endpoint: Bone marrow fibrosis evaluation. Started Sep 2018; status: recruiting.
02
Drugs
metformin
03
Conditions
primary myelofibrosis (PMF)
Beyond the preview
Go deeper on RBR-52ty66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-52ty66.